Propofol infusion syndrome (PRIS) is an uncommon life-threatening complication observed most often in patients receiving high-dose
propofol. High-dose
propofol treatment with a prolonged duration can damage the immune system. However, the associated molecular mechanisms remain unclear. An increasing number of clinical and experimental observations have demonstrated that tissue-resident macrophages play a critical role in immune regulation during anaesthesia and procedural sedation. Since the inflammatory response is essential for mediating
propofol-induced cell death and proinflammatory reactions, we hypothesised that
propofol overdose induces macrophage pyroptosis through
inflammasomes. Using primary cultured bone marrow-derived macrophages, murine macrophage cell lines (RAW264.7, RAW-asc and J774) and a mouse model, we investigated the role of NLRP3
inflammasome activation and secondary pyroptosis in
propofol-induced cell death. We found that high-dose
propofol strongly cleaved caspase-1 but not caspase-11 and biosynthesis of downstream
interleukin (IL)-1β and
IL-18. Inhibition of caspase-1 activity blocks IL-1β production. Moreover, NLRP3 deletion moderately suppressed cleaved caspase-1 as well as the proportion of pyroptosis, while levels of AIM2 were increased, triggering a compensatory pathway to pyroptosis in NLRP3-/- macrophages. Here, we show that
propofol-induced mitochondrial
reactive oxygen species (ROS) can trigger NLRP3
inflammasome activation. Furthermore, apoptosis-associated speck-like
protein (ASC) was found to mediate NLRP3 and AIM2 signalling and contribute to
propofol-induced macrophage pyroptosis. In addition, our work shows that
propofol-induced apoptotic initiator
caspase (caspase-9) subsequently cleaved
effector caspases (
caspase-3 and 7), indicating that both apoptotic and pyroptotic cellular death pathways are activated after
propofol exposure. Our studies suggest, for the first time, that
propofol-induced pyroptosis might be restricted to macrophage through an NLRP3/ASC/
caspase-1 pathway, which provides potential targets for limiting adverse reactions during
propofol application. These findings demonstrate that
propofol overdose can trigger cell death through caspase-1 activation and offer new insights into the use of anaesthetic drugs.